Medifast Q3 revenue down 19.4%, full-year loss guidance worse than consensus
FROM THE WIRE · SEEKINGALPHA.COM
* Medifast press release [https://seekingalpha.com/pr/20699337-medifast-announces-third-quarter-2026-financial-results] (MED [https://seekingalpha.com/symbol/MED]): Q3 Non-GAAP EPS of -$0.19 beats by $0.16. * Revenue of $72.05M (-19.4% Y/Y) beats by $0.75M. * Independent active…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishFalling revenue and full-year guidance worse than expected can weigh on the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Q3 2026 revenue was $72.0 million, down 19.4% year over year.
- 02Full-year 2026 revenue is expected between $280 and $300 million versus $287.7 million consensus.
- 03Full-year 2026 loss per share is expected between $1.80 and $2.05 versus -$1.15 consensus.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets